AbbVie Inc. (BIT:1ABBV)
Italy
· Delayed Price · Currency is EUR 171.40
+2.40 (1.42%)
At close: Aug 13, 2025, 5:30 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Immunology | 26.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Immunology Growth | 8.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology | 6.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Growth | 7.89% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Key Products | 3.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Key Products Growth | -4.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other | 3.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| All Other Growth | -10.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neuroscience | 9.00B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Neuroscience Growth | 19.03% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Women's Health Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Aesthetics | 5.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Aesthetics Growth | -6.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eye Care | 2.24B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Eye Care Growth | -3.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| United States | 43.03B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 5.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 13.31B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 6.31% |
Log In |
Log In |
Log In |
Log In | Upgrade
|